The two hallmarks of hepatocarcinogenesis associated with the c-myc/TGF-a are widespread dysplasia and profound chromosomal abnormalities. However, the most remarkable biological consequence of constitutive co-expression of c-myc and TGF-a transgenes is severe DNA damage. In 2-month-old double transgenic hepatocytes, the frequency of chromosomal breakage was increased nearly tenfold, whereas the number of aberrations observed in c-myc and TGF-a single transgenic hepatocytes was only 1.3- and 3-times background, respectively. Moreover, the presence of nonrandom chromosomal breaks recorded prior to tumor development and persistent enhancement of chromosomal damage in hepatocellular carcinomas suggested that TGF-a/c-myc hepatocytes exhibited a mutator phenotype. In light of recent evidence indicating that ligand binding to cell surface receptors linked to tyrosine kinase activity can trigger signal transduction pathways leading to production of intracellular reactive oxygen species (ROS), and given the known carcinogenic properties of ROS, we hypothesized that enhanced metabolic generation of oxygen radicals in rapidly proliferating c-myc/TGF-a transgenic hepatocytes might be responsible for genetic instability and acceleration of liver cancer in this animal model. By two months of age, production of ROS is significantly elevated in TGF-a/c-myc transgenic hepatocytes versus either wild type or c-myc single transgenic cells, and occurred in parallel with an increase in lipid peroxidation. Concomitantly with a rise in oxidant levels, antioxidant defenses were decreased, including total glutathione content and the activity of glutathione peroxidase. Furthermore, specific deletions were detected in mtDNA as early as five weeks of age in the transgenic mice. We conclude from these data that co-expression of TGF-a and c-myc transgenes in mouse liver promotes overproduction of ROS and thus creates an oxidative stress environment. This phenomenon may account for the massive DNA damage and acceleration of hepatocarcinogenesis observed in the TGF-a/c-myc mouse model.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005750-09
Application #
6558968
Study Section
(LEC)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Jensen, M R; Audolfsson, T; Factor, V M et al. (2000) In vivo expression and genomic organization of the mouse cyclin I gene (Ccni). Gene 256:59-67
Bouzahzah, B; Fu, M; Iavarone, A et al. (2000) Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo. Cancer Res 60:4531-7
Yoshiji, H; Kuriyama, S; Miyamoto, Y et al. (2000) Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32:1248-54
Hsia, C C; Nakashima, Y; Thorgeirsson, S S et al. (2000) Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma. Oncol Rep 7:353-6
Conner, E A; Lemmer, E R; Omori, M et al. (2000) Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene 19:5054-62
Arsura, M; Mercurio, F; Oliver, A L et al. (2000) Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol Cell Biol 20:5381-91
Thorgeirsson, S S; Factor, V M; Snyderwine, E G (2000) Transgenic mouse models in carcinogenesis research and testing. Toxicol Lett 112-113:553-5
Sanders, S; Keck-Waggoner, C L; Zimonjic, D B et al. (2000) Assignment of WDR7 (alias TRAG, TGF-beta resistance associated gene) to orthologous regions of human chromosome 18q21.1-->q22 and mouse chromosome 18D.1-E.3 by fluorescence in situ hybridization. Cytogenet Cell Genet 88:324-5
Lemmer, E R; Welch, J L; Tsai, T et al. (2000) Genomic structure and chromosome location of the mouse RelA p65 gene (Rela). Cytogenet Cell Genet 89:129-32
Yuan, B Z; Keck-Waggoner, C; Zimonjic, D B et al. (2000) Alterations of the FHIT gene in human hepatocellular carcinoma. Cancer Res 60:1049-53

Showing the most recent 10 out of 22 publications